Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-24 @ 10:55 PM
NCT ID:
NCT03606369
Eligibility Criteria:
Inclusion Criteria:
* Patients 18 years old or more.
* Not metastatic breast cancer confirmed with biopsy.
* Candidates to receive chemotherapy with anthracyclines combined with cyclophosphamide or carboplatin combined with docetaxel or docetaxel combined with cyclophosphamide.
* No previous treatment with radiotherapy or chemotherapy.
* Adequate hematologic function (Hb \>10 gr/dl, neutrophils \>1500, platelets \>100,000,) renal (Creatinine \<1.2 or creatinine depuration \>60 ml/min), hepatic (liver enzymes \<2.5 their normal value) and cardiologic (electrocardiogram).
* Adequate physical state (ECOG 0-1)
* Patients that accept to enter in protocol and sign the informed consent.
Exclusion Criteria:
* Prolonged QT (\>480 mseg)
* Comorbidities of the airway
* Intolerance to swallow medications
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03606369
Study Brief:
Protocol Section:
NCT03606369